Literature DB >> 15157172

The importance of resolution of inflammation in the pathogenesis of ANCA-associated vasculitis.

L Harper1, J M Williams, C O Savage.   

Abstract

The primary small-vessel systemic vasculitides are disorders that target small blood vessels, inducing vessel wall inflammation, and are associated with the development of anti-neutrophil cytoplasmic antibodies. Multiple organs are attacked, including the lungs and kidneys. Increasing knowledge of pathogenesis suggests that the antibodies activate neutrophils inappropriately, leading to endothelial and vascular damage. Cytokines, such as tumour necrosis factor, can facilitate damage by priming the neutrophils and activating endothelial cells. Apoptosis of infiltrating neutrophils is also disrupted by anti-neutrophil cytoplasmic antibody activation, and removal of these effete cells occurs in a pro-inflammatory manner, promoting persistent inflammation. The autoimmune response may be promoted by aberrant phagocytosis of apoptotic neutrophils by dendritic cells. Understanding the pathogenesis can help to rationalize existing therapies and indicate new approaches to therapy. Copyright 2004 Biochemical Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15157172     DOI: 10.1042/BST0320502

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  3 in total

Review 1.  Pathogenic role and clinical relevance of antineutrophil cytoplasmic antibodies in vasculitides.

Authors:  Ora Shovman; Boris Gilburd; Gisele Zandman-Goddard; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

2.  Impaired function of endothelial progenitor cells in children with primary systemic vasculitis.

Authors:  Ying Hong; Despina Eleftheriou; Nigel J Klein; Paul A Brogan
Journal:  Arthritis Res Ther       Date:  2015-10-16       Impact factor: 5.156

Review 3.  Central nervous system vasculitis.

Authors:  Neil J Scolding
Journal:  Semin Immunopathol       Date:  2009-11-12       Impact factor: 11.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.